FIELD: organic chemistry, medicine, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to the development of agents eliciting anti-hypoxic and antioxidant activity. Invention proposes an agent "Spirofen" of the general formula: C6n+6H4n+5NaO2n+5S2 that comprises a mixture of sodium salts of 5 sulfonylthio-derivatives of 2,2'-bi-, 2,2' : 3',2''-tri-, 2,2' : 3',2'' : 3'',2'''-tetra-, 2,2' : 3',2'' : 3'',2''' : 3''',2''''-penta- and 2,2' : 3',2'' : 3'',2''' : 3''',2'''' : 3''''-hexahydroqionones. Agent is prepared as powder, tablet, solution, capsule or emulsion. Invention provides expanding spectrum of the pharmacological effect and enhanced effectiveness in its applying.
EFFECT: valuable medicinal properties of agent.
3 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF POST-TRAUMATIC NEURODYSTROPHIC SYNDROME | 2007 |
|
RU2344819C1 |
| METHOD FOR INCREASING EFFECTIVENESS OF BASIC PSYCHOPHARMACOLOGICAL THERAPY OF MIXED ANXIETY AND DEPRESSIVE DISORDER | 2023 |
|
RU2817950C1 |
| METHOD OF TREATMENT OF PATHOLOGICAL SYNDROME AND MEDICINAL AGENT | 2000 |
|
RU2181297C2 |
| METHOD OF TREATING PATIENTS WITH POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2807874C1 |
| MEANS FOR CORRECTION OF PATHOLOGIC CONDITIONS ASSOCIATED WITH METABOLIC PROCESSES | 1997 |
|
RU2124888C1 |
| METHOD TO TREAT NEOVASCULOGENESIS AS A RESULT OF THROUGH KERATOPLASTY | 2000 |
|
RU2183120C2 |
| METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2016 |
|
RU2621875C1 |
| METHOD OF TREATING CHRONIC ENDOMETRITIS | 2012 |
|
RU2499594C1 |
| METHOD OF TREATING PATIENTS WITH SEVERE FORMS OF REPERFUSION SYNDROME COMPLICATED BY POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2808921C1 |
| METHOD OF TREATING PATIENTS WITH ABUSE HEADACHE | 2013 |
|
RU2547565C1 |
